James Investment Research’s Adient ADNT Stock Holding History

James Investment Research’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16	Closed	-$1K	–	573
2022 Q4	$1K	Buy	+16	New	+$559	﹤0.01%	553

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

James Investment Research's ADNT Position: Q1 2023 in Review

James Investment Research sold out of Adient (ADNT) in Q1 2023, closing a stake of 16 shares — an estimated $1K sold.

James Investment Research first reported a position in ADNT in Q4 2022 and held it in 1 quarter. The position peaked at $1K in Q4 2022. 275 funds tracked by Wall St. Rank hold ADNT as of Q1 2023.

James Investment Research reported no remaining Adient position as of Q1 2023 after selling out during the quarter.
James Investment Research sold 16 Adient shares in Q1 2023, an estimated $1K.
James Investment Research first reported a position in Adient in Q4 2022 and held it in 1 quarter.
James Investment Research's Adient position peaked at $1K in Q4 2022.
275 funds tracked by Wall St. Rank held Adient as of Q1 2023.

Based on James Investment Research's 13F filing for Q1 2023, filed 26 Apr 2023.